Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Jensen

Jensen Quality Mid Cap Fund Jensen Quality Mid Cap Fund - I Shares (JNVIX)

Ticker JNVIX · Since 2010-03-31 · · Holdings as of May 31, 2026

Expense ratio
0.82%$82/yr per $10k
5-yr return
+6.6%annualized
1-yr return
−2.4%as of Dec 2025
Net assets
$93.6Mall share classes
Holdings
37

Bottom line

Is JNVIX a good fund? The bottom line

JNVIX is a share class of Jensen Quality Mid Cap Fund, an actively managed mid-cap mutual fund from Jensen.

It charges 0.82% — about $82 a year on every $10,000 invested, cheaper than 60% of mid-cap funds we track.

It returned −2.4% over one year, +6.6% a year over five years, +9.4% a year over ten (as of Dec 31, 2025, per its prospectus).

With $93.6 million in net assets and 37 holdings, its largest position is Labcorp Holdings Inc (4.5%) and the top 10 make up 39.4% of the portfolio.

Updated Nov 19, 2026

What JNVIX invests in

The objective of the Jensen Quality Mid Cap Fund (the Quality Mid Cap Fund or the Fund) is long-term capital appreciation.

The Funds investment strategy seeks to identify companies the Adviser deems to be undervalued. To achieve its objective of long-term capital appreciation, the Fund invests in equity securities of companies that satisfy the investment criteria described below. Under normal circumstances, the Fund invests at least 80% of its net assets (plus borrowing for investment purposes) in equity securities of companies meeting the criteria for quality and mid-capitalization as determined by the Adviser. The Adviser considers a company to be a mid-capitalization company if it is listed in the MSCI U.S. Mid Cap 450 Index at the time that the Adviser creates the Funds investable universe. The Adviser considers a company to be a quality company if it possesses competitive advantages as evidenced by generating a return on equity of 15% or greater for at least ten consecutive fiscal years as determined…

From the fund's prospectus (filed Sep 25, 2026).

JNVIX performance

Average annual total returns
1 yr5 yr10 yr
JNVIX−2.4%+6.6%+9.4%
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full JNVIX performance history →

What JNVIX costs

On a $10,000 investment, JNVIX's 0.82% expense ratio costs about $82 a year. The prospectus estimates $1,111 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full JNVIX fee table →

JNVIX top 10 holdings

#Holding% of fund
1Labcorp Holdings Inc LH4.46%
2Encompass Health Corp EHC4.34%
3Ross Stores Inc ROST4.27%
4Motorola Solutions Inc MSI4.16%
5Kroger Co/The KR4.04%
6F5 Inc FFIV3.74%
7WW Grainger Inc GWW3.69%
8Crown Holdings Inc CCK3.63%
9MSCI Inc MSCI3.56%
10Sherwin-Williams Co/The SHW3.53%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 39.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to JNVIX

More funds like JNVIX →

JNVIX FAQ

What is the expense ratio of JNVIX?
JNVIX's expense ratio is 0.82%, which works out to about $82 a year for every $10,000 invested. The prospectus estimates total costs of $1,111 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is JNVIX a good investment?
It depends on your goals, but the data points to: a typical fund for its category. This is general information, not personalized advice.
What does JNVIX hold?
JNVIX's largest holdings are Labcorp Holdings Inc (4.5%), Encompass Health Corp (4.3%), Ross Stores Inc (4.3%), Motorola Solutions Inc (4.2%), Kroger Co/The (4.0%). It holds 37 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is JNVIX's 5-year return?
JNVIX returned +6.6% a year over the five years ending Dec 31, 2025, and +9.4% a year over ten years. Past performance does not guarantee future results.
Who manages JNVIX?
JNVIX is offered by Jensen through Trust For Professional Managers.